نتایج جستجو برای: mtx sensor

تعداد نتایج: 192151  

2016
Tatsuya Atsumi Kazuhiko Yamamoto Tsutomu Takeuchi Hisashi Yamanaka Naoki Ishiguro Yoshiya Tanaka Katsumi Eguchi Akira Watanabe Hideki Origasa Shinsuke Yasuda Yuji Yamanishi Yasuhiko Kita Tsukasa Matsubara Masahiro Iwamoto Toshiharu Shoji Toshiyuki Okada Désirée van der Heijde Nobuyuki Miyasaka Takao Koike

OBJECTIVES To evaluate efficacy and safety of combination therapy using certolizumab pegol (CZP) and methotrexate (MTX) as first-line treatment for MTX-naive, early rheumatoid arthritis (RA) with poor prognostic factors, compared with MTX alone. METHODS MTX-naive, early RA patients with ≤12 months persistent disease, high anti-cyclic citrullinated peptide, and either rheumatoid factor positiv...

2017
Hal A. Lewis Kathleen M. Nemer Rebecca J. Chibnall Amy C. Musiek

H&E: hematoxylin-eosin stain MTX: methotrexate RA: rheumatoid arthritis INTRODUCTION Methotrexate (MTX) is a commonly prescribed medication in the treatment of autoimmune conditions such as rheumatoid arthritis (RA) and psoriasis. MTX is a folic acid analog and DNA synthesis inhibitor that competitively inhibits dihydrofolate reductase. Well-known side effects of MTX include diarrhea, nausea/vo...

2007
J. Braun P. Kästner P. Flaxenberg J. Währisch P. Hanke W. Demary U. von Hinüber K. Rockwitz W. Heitz U. Pichlmeier C. Guimbal-Schmolck

Objective. To compare the efficacy and safety of subcutaneous (SC) versus oral administration of methotrexate (MTX) in patients with active rheumatoid arthritis (RA). Methods. MTX-naive patients with active RA (Disease Activity Score in 28 joints >4) were eligible for the study if they had not previously taken biologic agents and had not taken disease-modifying antirheumatic drugs for 2 weeks p...

Journal: :Cancer research 2004
Pauline Breedveld Noam Zelcer Dick Pluim Ozgür Sönmezer Matthijs M Tibben Jos H Beijnen Alfred H Schinkel Olaf van Tellingen Piet Borst Jan H M Schellens

The antifolate drug methotrexate (MTX) is transported by breast cancer resistance protein (BCRP; ABCG2) and multidrug resistance-associated protein1-4 (MRP1-4; ABCC1-4). In cancer patients, coadministration of benzimidazoles and MTX can result in profound MTX-induced toxicity coinciding with an increase in the serum concentrations of MTX and its main metabolite 7-hydroxymethotrexate. We hypothe...

Journal: :Cancer research 1985
G Fabre I D Goldman

The rapid synthesis of poly-gamma-glutamyl derivatives of 7-hydroxymethotrexate (7-OH-MTX) and their selective intracellular retention are reported in human chronic myelogenous leukemia cells, K-562. After a 30-min exposure to 5 microM [3H]7-OH-MTX, three different polyglutamyl derivatives were detected by high-performance liquid chromatography. When extracellular 7-OH-MTX was removed, the 7-OH...

Journal: :Blood 2013
Susanne Radtke Oliver Zolk Bertold Renner Marios Paulides Martin Zimmermann Anja Möricke Martin Stanulla Martin Schrappe Thorsten Langer

The pharmacogenetics of methotrexate (MTX) was investigated in a large cohort of pediatric patients with acute lymphoblastic leukemia (ALL). Four hundred ninety-nine children with ALL from the ALL-BFM (Berlin-Frankfurt-Münster) 2000 trial who received 1996 courses of MTX at 5 g/m(2) were genotyped for 8 single nucleotide polymorphisms in 5 candidate genes of the MTX/folate pathway. Patients' MT...

Journal: :The Journal of rheumatology 2016
Jeffrey R Curtis Vivian P Bykerk Maher Aassi Michael Schiff

OBJECTIVE Medication adherence in patients with rheumatoid arthritis (RA) is typically suboptimal. Nonadherence has been associated with symptom worsening and increased disability. We systematically reviewed published clinical studies to evaluate methotrexate (MTX) adherence and persistence, factors associated with MTX adherence and persistence, and the effect of MTX nonadherence on clinical ou...

2018
Arthur Kavanaugh Ronald F van Vollenhoven Roy Fleischmann Paul Emery Iain Sainsbury Stefan Florentinus Su Chen Benoît Guérette Hartmut Kupper Josef S Smolen

OBJECTIVES To compare responses in patients with early rheumatoid arthritis (RA) initially treated with the tumour necrosis factor inhibitor (TNFi) adalimumab+methotrexate (MTX) versus MTX monotherapy who may have continued receiving MTX or switched to adalimumab rescue therapy after inadequate response to MTX. METHODS OPTIMA enrolled MTX-naive patients with active RA for <1 year. This post h...

Journal: :Toxicological sciences : an official journal of the Society of Toxicology 2007
Glenn S Belinsky Ann L Parke Qihong Huang Kerry Blanchard Supriya Jayadev Raymond Stoll Marti Rothe Luke E K Achenie Rishi R Gupta George Y Wu Daniel W Rosenberg

Long-term administration of methotrexate (MTX) for management of chronic inflammatory diseases is associated with risk of liver damage. In this study, we examined the transcriptional profiles of livers from patients treated with MTX. The possibility that expression signatures correlate with grade of fibrosis or underlying rheumatic disease was evaluated. Twenty-seven patients taking MTX were ac...

Journal: :Acta cirurgica brasileira 2015
Esra Erdogan Yasin Ilgaz Pinar Naile Gurgor Yesim Oztas Turgut Topal Emin Oztas

PURPOSE To investigate the possible protective effect of rutin on methotrexate induced hepatotoxicity in rats. METHODS Twenty-two rats were divided into three experimental groups; Control-saline, Mtx, Mtx+Rutin. Hepatic tissue was taken for histological assessment and biochemical assays. Oxidative stress parameters malondialdehyde (MDA), glutathione peroxidase (GSH-Px) and superoxide dismutas...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید